Ann: Trading Halt, page-12

Any thing to do with this...sound so familiar

"During the Quarter, the Company successfully commenced a small-scale commercial trial for a new
Joint Health Supplement produced using MicroMAX® technology, under a new direct to consumer
brand on the Amazon platform in the U.S.
MicroMAX® is a patented encapsulation technology platform designed to encapsulate microscopic
droplets of oil in a special food grade material, to protect bioactive ingredients from oxidation, and
help deliver them to the gastrointestinal (GI) tract for better absorption.
In January 2020, CannPal was granted the global exclusive rights to commercialise patented
MicroMAX® microencapsulation technology by the commonwealth scientific and Industrial research
organisation (CSIRO) for use in the field of Animal Therapeutics [ASX Announcement: Jan 6, 2020]."